Rapid determination of the encapsulation efficiency of a liposome formulation using column-switching HPLC

Ohnishi, Naozumi; Yamamoto, Eiichi; Tomida, Hiromasa; Hyôdô, Kenji; Ishiguro, Hiroshi; Kikuchi, Hiroshi; Tahara, Kohei; Takeuchi, Hirofumi

doi:10.1016/j.ijpharm.2012.12.019

Cited by 36 publications

(21 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…26) However, method verification was additionally conducted with respect to recovery of DXR from EPC and EPC+ HSPC liposome formulations because the detailed lipid components were different from the previous one. Recovery of DXR from Doxil ® was validated in the previous study.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Characterization of a Doxorubicin Liposome Formulation by a Novel <i>in Vitro</i> Release Test Methodology Using Column-Switching High-Performance Liquid Chromatography

et al. 2014

Self Cite

View full text Add to dashboard Cite

A novel in vitro release test methodology for a liposome formulation was developed using a columnswitching high-performance liquid chromatography (HPLC) system. Doxorubicin (DXR) liposome formulations were used as a model. A DXR liposome formulation was dispersed into a release medium, and the dispersion fluid was directly injected at predetermined time points into the column-switching HPLC system. To evaluate the release profile, this system can be used for determining the released and encapsulated DXR in the liposome formulation separately. Comparison with a conventional in vitro release test methodology by dialysis revealed that the methodology developed by column-switching HPLC had no rate-limiting process of membrane permeation of the drug (which is occasionally observed in the dialysis method). The in vitro release profiles of DXR liposome formulations were well characterized using the method developed by column-switching HPLC, and different in vitro release characteristics were revealed. The developed method did not require a large amount of sample or a complicated pretreatment. In addition, the developed columnswitching HPLC system was applicable for characterization of the encapsulation profile of liposome formulations.Key words doxorubicin; Doxil ® ; dialysis; solid-phase extraction; encapsulation Several studies of pharmaceutical formulations for drugdelivery systems (DDS), such as liposomes, microspheres, and nanosuspensions, have been conducted. Their advantages, such as targeted/controlled delivery, enhanced efficacy, and reduced toxicity, have been verified. [1][2][3][4] However, the number of approved and marketed pharmaceutical products with DDS technology is limited. The reasons for this are thought to be the difficulty of robust mass production as well as the lack of sophisticated quality control accompanied by a deep understanding of in vitro and in vivo characteristics. With regard to liposome formulations, the enhanced permeability and retention (EPR) effect of polyethylene glycol-conjugated liposomes has been demonstrated in several studies, and are very attractive as passive targeting methods of antitumor agents. [5][6][7][8][9] Considerable efforts are being made for the development of several administration routes for liposomes, such as inhalational, transdermal, and ocular in addition to injection. [10][11][12][13][14] In contrast, analytical technology for liposome formulations may not be sufficiently mature to assure efficacy and safe performance as well as to direct the optimization of formulations or improvements in manufacturing processes. Drug release characteristics are considered to be one of the important properties to assure the performance of liposome formulations. 15)These characteristics may change depending on the lot-to-lot variation of ingredients and/or changes in manufacturing processes such as scale-up. The importance of evaluation of the in vitro release characteristics is increasing and it is one of the regulatory requirements. [16][17][18][19] Although in vitro re...

show abstract

Section: Resultsmentioning

confidence: 99%

“…We previously reported the methodology of the column-switching HPLC system in detail. 26) A sche- matic representation of the column-switching HPLC system is shown in Fig. A1.…”

Section: Preparation Of Dxr Liposomesmentioning

confidence: 99%

Characterization of a Doxorubicin Liposome Formulation by a Novel <i>in Vitro</i> Release Test Methodology Using Column-Switching High-Performance Liquid Chromatography

et al. 2014

Self Cite

View full text Add to dashboard Cite

show abstract

“…It generally allows the full automation of the analytical procedure and hence, a strong reproducibility. Moreover, SPE has already been successfully applied for liposomes (8,9), suggesting that it may be suitable for lipid nanoparticles (LNP) as well. This paper deals with the development of SPE 6 methods to quantify separately free and entrapped cyclosporine A in a patented nanocarrier: Lipidot ® (10).…”

Section: Introductionmentioning

confidence: 99%

Solid Phase Extraction as an Innovative Separation Method for Measuring Free and Entrapped Drug in Lipid Nanoparticles

et al. 2015

View full text Add to dashboard Cite

“…Dialysis and gel filtration can separate these two types of drugs on the basis of difference in particle size, and ultracentrifugation is based on difference in density. In addition, we previously reported a column-switching HPLC system that separates unloaded drug and encapsulated drug in liposomal formulation or plasma, using doxorubicin as a model low molecular weight drug (Ohnishi et al, 2013;Yamamoto et al, 2011). The column-switching HPLC system can automatically separate and evaluate unloaded and encapsulated drugs in liposomal formulations on the basis of difference in hydrophobic interaction in a solid-phase extraction (SPE) column.…”

mentioning

confidence: 99%

“…The fundamental principle of the columnswitching HPLC system was previously reported (Ohnishi et al, 2013). A schematic representation of the column-switching HPLC system and the optimized operating conditions are shown in Supplementary Fig.…”

mentioning

confidence: 99%

Characterization of insulin-loaded liposome using column-switching HPLC

Ohnishi

Tanaka

Tahara

et al. 2015

International Journal of Pharmaceutics

Self Cite

View full text Add to dashboard Cite

Rapid determination of the encapsulation efficiency of a liposome formulation using column-switching HPLC

Cited by 36 publications

References 33 publications

Characterization of a Doxorubicin Liposome Formulation by a Novel <i>in Vitro</i> Release Test Methodology Using Column-Switching High-Performance Liquid Chromatography

Characterization of a Doxorubicin Liposome Formulation by a Novel <i>in Vitro</i> Release Test Methodology Using Column-Switching High-Performance Liquid Chromatography

Solid Phase Extraction as an Innovative Separation Method for Measuring Free and Entrapped Drug in Lipid Nanoparticles

Characterization of insulin-loaded liposome using column-switching HPLC

Contact Info

Product

Resources

About